• Sitemap
  • Contact us

pISSN 2950-9114 eISSN 2950-9122
Article View

Original Article

Lab Med Qual Assur 2022; 44(4): 204-211

Published online December 31, 2022

https://doi.org/10.15263/jlmqa.2022.44.4.204

Copyright © Korean Association of External Quality Assessment Service.

Feasibility of Establishing a Common Cut-Off of Human Leukocyte Antigen Flow Cytometry Crossmatch Using Harmonized Protocols in a Multicenter Setting

Hae In Bang1 , Younhee Park2 , Eun Young Song3 , Eun-Jee Oh4 , Jong-Han Lee5 , and Eun-Suk Kang6

1Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital; 2Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine; 3Department of Laboratory Medicine, Seoul National University College of Medicine; 4Department of Laboratory Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul; 5Department of Laboratory Medicine, Yonsei University Wonju College of Medicine, Wonju; 6Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Correspondence to:Eun-Suk Kang
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea
Tel +82-2-3410-2703
E-mail eskang@skku.edu

Received: July 6, 2022; Revised: August 10, 2022; Accepted: August 11, 2022

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background: The results of human leukocyte antigen flow cytometry crossmatch (FCXM) are widely used when making transplant decisions. However, standardization/harmonization is required because the results vary between laboratories. A harmonized test method was reported to reduce interlaboratory variability. In this study, we evaluated the feasibility of establishing common cut-off values using a harmonized method in multicenter settings.
Methods: Six laboratories participated in the study and conducted FCXM using a harmonized test method. Tests were performed using two donor cells and 25 negative sera samples. As a negative control (NC), laboratory NC (Lab NC) and a common NC (Korea Organ Donation Agency [KODA] NC) were included simultaneously. Median fluorescent intensity (MFI) ratios were calculated for each NC, and means ±2 standard deviation (SD) and ±3SD were estimated for the MFI ratio.
Results: The suggested cut-off values based on the mean ±2SD and ±3SD of the MFI ratio data from 144 non-pronase T cell crossmatch after excluding one positive result were 1.6 and 1.9 using Lab NC and 1.3 and 1.5 using KODA NC, respectively. For pronase B cell crossmatch, values of 1.4 and 1.6 using Lab NC and 1.3 and 1.5 using KODA NC were obtained for the mean ±2SD and ±3SD of the MFI ratio, respectively. Inter-laboratory variations of non-pronase T cell crossmatch and pronase B cell crossmatch were less than 30% when using Lab NC and KODA NC.
Conclusions: Variations in FCXM between laboratories were within the tolerable range when the harmonized method and same negative sera were applied. Therefore, applying common cut-off values with a standardized protocol may be feasible in multicenter settings.

Keywords: Human leukocyte antigen, Flow cytometry, Crossmatch, Harmonized method, Cut-off

Supplementary File


Share this article on :

Stats or metrics